广东医学2024，Vol.45Issue(9)：1137-1142,6.DOI:10.13820/j.cnki.gdyx.20241366
镜像神经元疗法治疗中风后复杂性区域疼痛综合征Ⅰ期的疗效及对血清SP、CGRP水平的影响
Efficacy of mirror neuron therapy in treating phase Ⅰ complex regional pain syndrome post-stroke and its effects on serum substance P and calcitonin gene-related peptide levels
摘要
Abstract
Objective To explore the clinical efficacy and mechanism of mirror neuron therapy in the treatment of phase Ⅰ complex regional pain syndrome(CRPS)following stroke.Methods A total of 40 patients with CRPS phaseⅠ were selected from the Rehabilitation Department for this study.The patients were randomly divided into a control group and a mirror therapy group,with 20 patients in each group.Both groups received basic and conventional rehabilitation treatments,while the mirror therapy group additionally received mirror therapy.Treatment was administered twice daily,five times per week,for three weeks.Pain in the shoulder joint was evaluated using the Resting State Visual Analogue Scale(R-VAS)and the Passive Movement State Visual Analogue Scale(P-VAS).Hand swelling was assessed using the water displacement method,and upper limb motor function was evaluated with the Fugl-Meyer scale.Serum levels of calcitonin gene-related peptide(CGRP)and substance P(SP)were measured using ELISA.Results After three weeks of treatment,patients in the mirror therapy group showed lower R-VAS and P-VAS scores,reduced hand swell-ing,and higher Fugl-Meyer scores compared to the control group(P＜0.05).Additionally,the mirror therapy group had lower serum SP levels and higher CGRP levels than the control group(P＜0.05).Conclusion Mirror therapy is more effective in alleviating shoulder joint pain,hand swelling,and upper limb dysfunction in CRPS phase Ⅰ patients,and it regulates serum CGRP and SP levels.关键词
中风/镜像神经元疗法/复杂性区域疼痛综合征Ⅰ期/肩关节疼痛/P物质/血清降钙素基因相关肽Key words
stroke/mirror neuron therapy/complex regional pain syndromestage Ⅰ/shoulder pain/substance P/calcitonin gene-related peptide分类
医药卫生引用本文复制引用
宋宇锦,张伟,温红娟,王静,张裴景,冯慧利,王慧灵,常译牛,任彬彬..镜像神经元疗法治疗中风后复杂性区域疼痛综合征Ⅰ期的疗效及对血清SP、CGRP水平的影响[J].广东医学,2024,45(9):1137-1142,6.基金项目
河南省中医药科学研究专项课题(2021ZY2182,2019JDZX2111,2019JDZX2016) （2021ZY2182,2019JDZX2111,2019JDZX2016）
河南省中医药拔尖人才培养项目专题课题项目(2022ZYBJ09). （2022ZYBJ09）
